Proceedings of the Health Science International Conference (HSIC 2017)

Indicaxanthin, Miraxanthin-V, and Hexahydrocurcumin as Potential Erythropoietin Agonist in Silico to Treat Anemia in Chronic Kidney Disease

Authors
Yuliana Suselo, Kamil Kamil, Sri Wulandari, Dono Indarto
Corresponding Author
Yuliana Suselo
Available Online October 2017.
DOI
https://doi.org/10.2991/hsic-17.2017.62How to use a DOI?
Keywords
Agonist Erythropoietin, Anemia, CKD, Phythochemicals, Molecular Docking
Abstract

Anemia is the most frequent complication of Chronic Kidney Disease (CKD) which is mainly caused by erythropoietin (Epo) deficiency. Epo agonist is the drug choice for anemia in CKD but some patients have antibody against Epo agonist. Objectives: This study aimed to identify Indonesian medicinal plants that have an agonist activity to Epo receptor in silico. Method: This was a bioinformatics study with using all Indonesian phytochemicals which were registered in HerbalDB and had the 3-D in PubChem. The Epo-EpoR complexes were used as standard ligand and receptor with the Protein Data Bank code 1CN4. Because Epo and EpoR sizes were bigger than 1,500 Da, the molecules were truncated validated 3 times using AutodockVina 1.1.2. and all phytochemicals were molecularly docked using the same method. Docking results were visualized using PyMOL 1.7.4. Results: Truncated Epo interacted with EpoR in 9 different binding sites with average of binding affinity ranging from -2.6 to -5.5 kcal/mol. Indicaxanthin, Miraxanthin-V, and Hexahydrocurcumin had lower binding affinity than standard in each binding sites. Similar binding sites to EpoR were founded in Indicaxanthin. Conclusion: Indicaxanthin, Miraxanthin-V, and Hexahydrocurcumin were potential as Epo agonist in silico to treat anemia in CKD.

Copyright
© 2017, the Authors. Published by Atlantis Press.
Open Access
This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

Volume Title
Proceedings of the Health Science International Conference (HSIC 2017)
Series
Advances in Health Sciences Research
Publication Date
October 2017
ISBN
978-94-6252-413-2
ISSN
2468-5739
DOI
https://doi.org/10.2991/hsic-17.2017.62How to use a DOI?
Copyright
© 2017, the Authors. Published by Atlantis Press.
Open Access
This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Cite this article

TY  - CONF
AU  - Yuliana Suselo
AU  - Kamil Kamil
AU  - Sri Wulandari
AU  - Dono Indarto
PY  - 2017/10
DA  - 2017/10
TI  - Indicaxanthin, Miraxanthin-V, and Hexahydrocurcumin as Potential Erythropoietin Agonist in Silico to Treat Anemia in Chronic Kidney Disease
BT  - Proceedings of the Health Science International Conference (HSIC 2017)
PB  - Atlantis Press
SP  - 399
EP  - 410
SN  - 2468-5739
UR  - https://doi.org/10.2991/hsic-17.2017.62
DO  - https://doi.org/10.2991/hsic-17.2017.62
ID  - Suselo2017/10
ER  -